High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea

scientific article published on 13 December 2010

High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MEEGID.2010.11.010
P932PMC publication ID3728899
P698PubMed publication ID21147267

P50authorPeter A. ZimmermanQ39408524
Cara N. HalldinQ56811222
P2093author name stringChristopher L King
Moses Bockarie
David T McNamara
Melinda Susapu
Daphne Sepe
P2860cites workThe international limits and population at risk of Plasmodium vivax transmission in 2009Q21144525
Evolutionary and historical aspects of the burden of malariaQ24535657
Genetic diversity of Plasmodium vivax isolates from AzerbaijanQ24800381
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1Q24805474
The neglected burden of Plasmodium vivax malariaQ29618450
Evolutionary dynamics of the immunodominant repeats of the Plasmodium vivax malaria-vaccine candidate circumsporozoite protein (CSP).Q33769886
Plasmodium vivax malaria vaccine developmentQ34462082
Genetic diversity of Plasmodium vivax in Kolkata, IndiaQ35017420
Mapping the global extent of malaria in 2005.Q35034339
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoitesQ35689495
An update on the search for a Plasmodium vivax vaccineQ36720449
Malaria infections are randomly distributed in diverse holoendemic areas of Papua New GuineaQ37058426
Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assayQ37058435
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis.Q37058594
Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens.Q37123836
High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New GuineaQ37132076
Plasmodium vivax circumsporozoite variants and Duffy blood group genotypes in the Brazilian Amazon regionQ37274492
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialQ38410749
High frequency of genetic diversity of Plasmodium vivax field isolates in MyanmarQ38498440
Susceptibility of Anopheles aquasalis and an. darlingi to Plasmodium vivax VK210 and VK247.Q38959586
Response of Plasmodium vivax variants to chloroquine as determined by microscopy and quantitative polymerase chain reaction.Q39115531
Detection of Plasmodium vivax by polymerase chain reaction in a field studyQ39115539
Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from IranQ39621641
The population dynamics in mosquitoes and humans of two Plasmodium vivax polymorphs distinguished by different circumsporozoite protein repeat regions.Q41104769
Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzeeQ41915796
Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatmentQ41920647
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity.Q41932684
Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasionQ42051683
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaQ44164504
Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markersQ44461768
Random distribution of mixed species malaria infections in Papua New Guinea.Q46547100
Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoitesQ46662804
Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeysQ47835703
Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitopeQ47886592
Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.Q47894112
Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding proteinQ47911026
Genetic structure of Plasmodium vivax isolates from two malaria endemic areas in AfghanistanQ47912736
Genetic diversity and multiple infections of Plasmodium vivax malaria in Western ThailandQ47930983
Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite proteinQ47999989
Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasionQ48004710
Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccineQ48019407
Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeysQ48036717
Genetic diversity of Plasmodium vivax Pvcsp and Pvmsp1 in Guyana, South AmericaQ48036850
Diversity and natural selection in Plasmodium vivax Duffy binding protein geneQ56379448
P4510describes a project that usesImageQuantQ112270642
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectPapua New GuineaQ691
malariaQ12156
Plasmodium vivaxQ311376
P304page(s)391-398
P577publication date2010-12-13
P1433published inInfection, Genetics and EvolutionQ4041378
P1476titleHigh-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea
P478volume11

Reverse relations

cites work (P2860)
Q48017006Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control
Q28544002Comparative analysis of field-isolate and monkey-adapted Plasmodium vivax genomes
Q30439881Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens
Q37668739Genetic diversity of Plasmodium Vivax in South of Iran: A cross-sectional study
Q37107966High genetic diversity of Plasmodium vivax on the north coast of Papua New Guinea
Q36023507Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas
Q37924602Molecular markers and genetic diversity of Plasmodium vivax
Q37394822Serological markers to measure recent changes in malaria at population level in Cambodia
Q37357825Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population
Q26865002The utility of genomic data for Plasmodium vivax population surveillance
Q17485678Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination